Simona Della Valle , Anna Faber , Roland J Politan , Suman Lama , Georg Fritz
{"title":"From marsh to market: taming Vibrio natriegens for sustainable bioproduction","authors":"Simona Della Valle , Anna Faber , Roland J Politan , Suman Lama , Georg Fritz","doi":"10.1016/j.copbio.2025.103353","DOIUrl":null,"url":null,"abstract":"<div><div>As the fastest-growing bacterium known to date, <em>Vibrio natriegens</em> is rapidly emerging as a promising chassis for biotechnology. Here, we explore its development towards sustainable bioproduction. Several innate traits underpin this progress, including the ability to metabolise next-generation feedstocks such as formate, acetate, and glycerol, as well as its halotolerance. Recent advances in genome engineering, synthetic biology tools, and systems-level analyses have enabled the application of <em>V. natriegens</em> in increasingly efficient bioprocesses. Yet, important constraints persist, particularly in achieving high product yields and processing recalcitrant substrates. We propose that these limitations can be addressed through a systems biotechnology approach, coupling strain and process engineering to guide the rational optimisation of <em>V. natriegens</em> for scalable, next-generation biomanufacturing.</div></div>","PeriodicalId":10833,"journal":{"name":"Current opinion in biotechnology","volume":"96 ","pages":"Article 103353"},"PeriodicalIF":7.0000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current opinion in biotechnology","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0958166925000977","RegionNum":2,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
As the fastest-growing bacterium known to date, Vibrio natriegens is rapidly emerging as a promising chassis for biotechnology. Here, we explore its development towards sustainable bioproduction. Several innate traits underpin this progress, including the ability to metabolise next-generation feedstocks such as formate, acetate, and glycerol, as well as its halotolerance. Recent advances in genome engineering, synthetic biology tools, and systems-level analyses have enabled the application of V. natriegens in increasingly efficient bioprocesses. Yet, important constraints persist, particularly in achieving high product yields and processing recalcitrant substrates. We propose that these limitations can be addressed through a systems biotechnology approach, coupling strain and process engineering to guide the rational optimisation of V. natriegens for scalable, next-generation biomanufacturing.
期刊介绍:
Current Opinion in Biotechnology (COBIOT) is renowned for publishing authoritative, comprehensive, and systematic reviews. By offering clear and readable syntheses of current advances in biotechnology, COBIOT assists specialists in staying updated on the latest developments in the field. Expert authors annotate the most noteworthy papers from the vast array of information available today, providing readers with valuable insights and saving them time.
As part of the Current Opinion and Research (CO+RE) suite of journals, COBIOT is accompanied by the open-access primary research journal, Current Research in Biotechnology (CRBIOT). Leveraging the editorial excellence, high impact, and global reach of the Current Opinion legacy, CO+RE journals ensure they are widely read resources integral to scientists' workflows.
COBIOT is organized into themed sections, each reviewed once a year. These themes cover various areas of biotechnology, including analytical biotechnology, plant biotechnology, food biotechnology, energy biotechnology, environmental biotechnology, systems biology, nanobiotechnology, tissue, cell, and pathway engineering, chemical biotechnology, and pharmaceutical biotechnology.